1. Home
  2. ENZ vs COEP Comparison

ENZ vs COEP Comparison

Compare ENZ & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENZ
  • COEP
  • Stock Information
  • Founded
  • ENZ 1976
  • COEP 2017
  • Country
  • ENZ United States
  • COEP United States
  • Employees
  • ENZ N/A
  • COEP N/A
  • Industry
  • ENZ Medical Specialities
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ENZ Health Care
  • COEP Health Care
  • Exchange
  • ENZ Nasdaq
  • COEP Nasdaq
  • Market Cap
  • ENZ 34.2M
  • COEP 32.4M
  • IPO Year
  • ENZ N/A
  • COEP N/A
  • Fundamental
  • Price
  • ENZ $0.54
  • COEP $11.50
  • Analyst Decision
  • ENZ
  • COEP
  • Analyst Count
  • ENZ 0
  • COEP 0
  • Target Price
  • ENZ N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • ENZ 125.9K
  • COEP 136.7K
  • Earning Date
  • ENZ 03-12-2025
  • COEP 03-25-2025
  • Dividend Yield
  • ENZ N/A
  • COEP N/A
  • EPS Growth
  • ENZ N/A
  • COEP N/A
  • EPS
  • ENZ N/A
  • COEP N/A
  • Revenue
  • ENZ $30,314,000.00
  • COEP N/A
  • Revenue This Year
  • ENZ N/A
  • COEP N/A
  • Revenue Next Year
  • ENZ N/A
  • COEP N/A
  • P/E Ratio
  • ENZ N/A
  • COEP N/A
  • Revenue Growth
  • ENZ N/A
  • COEP N/A
  • 52 Week Low
  • ENZ $0.54
  • COEP $2.31
  • 52 Week High
  • ENZ $1.40
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • ENZ 25.45
  • COEP 57.31
  • Support Level
  • ENZ $0.54
  • COEP $8.65
  • Resistance Level
  • ENZ $0.69
  • COEP $11.75
  • Average True Range (ATR)
  • ENZ 0.03
  • COEP 2.11
  • MACD
  • ENZ 0.00
  • COEP -0.28
  • Stochastic Oscillator
  • ENZ 7.73
  • COEP 53.32

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: